BPG is committed to discovery and dissemination of knowledge
Case Control Study
Copyright: ©Author(s) 2026.
World J Clin Oncol. Oct 24, 2026; 17(10): 125453
Published online Oct 24, 2026. doi: 10.5306/wjco.125453
Table 1 Baseline demographics and significant clinical characteristics (n = 200), n (%)
Variable
Overall (n = 200)
Stage I (n = 68)
Stage II (n = 65)
Stage III (n = 22)
Stage IV (n = 45)
P value
Age (years)52.9 ± 16.451.2 ± 15.454.3 ± 19.356.1 ± 12.452.0 ± 15.00.532
Gender0.727
    Female88 (44.0)27 (39.7)32 (49.2)10 (45.5)19 (42.2)
    Male112 (56.0)41 (60.3)33 (50.8)12 (54.5)26 (57.8)
Histological Dx0.034a
    Adenocarcinoma129 (64.5)43 (63.2)38 (58.5)20 (90.9)28 (62.2)
    Others71 (35.5)25 (36.8)27 (41.5)2 (9.1)17 (37.8)
Histological grade0.001b
    Well47 (23.5)14 (20.6)18 (27.7)6 (27.3)9 (20.0)
    Moderate48 (24.0)13 (19.1)14 (21.5)5 (22.7)16 (35.6)
    Poorly47 (23.5)9 (13.2)14 (21.5)10 (45.5)14 (31.1)
    Atypical58 (29.0)32 (47.1)19 (29.2)1 (4.5)6 (13.3)
H. pylori (histology)0.042a
    Positive130 (65.0)36 (52.9)48 (73.8)17 (77.3)29 (64.4)
    Negative70 (35.0)32 (47.1)17 (26.2)5 (22.7)16 (35.6)
Survival status< 0.001b
    Deceased65 (32.5)15 (22.1)17 (26.2)10 (45.5)23 (51.1)
    Under treatment82 (41.0)15 (22.1)36 (55.4)11 (50.0)20 (44.4)
    Cured53 (26.5)38 (55.9)12 (18.5)1 (4.5)2 (4.4)


Write to the Help Desk